Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 1,000 Shares

Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 1,000 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $50.00, for a total transaction of $50,000.00. Following the sale, the director now directly owns 299,695 shares in the company, valued at $14,984,750. This trade represents a 0.33 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Pro-Dex Trading Down 0.8 %

PDEX traded down $0.38 during trading on Tuesday, reaching $49.62. 46,320 shares of the company's stock were exchanged, compared to its average volume of 21,842. The company's fifty day moving average price is $39.84 and its 200-day moving average price is $39.42. The firm has a market capitalization of $161.81 million, a PE ratio of 24.69 and a beta of 0.68. Pro-Dex, Inc. has a fifty-two week low of $16.84 and a fifty-two week high of $59.60. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 2.58.

Pro-Dex (NASDAQ:PDEX - Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The medical instruments supplier reported $0.61 EPS for the quarter, beating analysts' consensus estimates of $0.38 by $0.23. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. As a group, equities analysts forecast that Pro-Dex, Inc. will post 2 EPS for the current year.

Remove Ads

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of PDEX. OMERS ADMINISTRATION Corp bought a new position in shares of Pro-Dex during the fourth quarter worth $313,000. Millennium Management LLC acquired a new stake in Pro-Dex during the 4th quarter worth $260,000. 683 Capital Management LLC bought a new position in Pro-Dex during the fourth quarter worth about $739,000. Northern Trust Corp lifted its holdings in Pro-Dex by 14.1% during the fourth quarter. Northern Trust Corp now owns 35,754 shares of the medical instruments supplier's stock worth $1,672,000 after acquiring an additional 4,426 shares in the last quarter. Finally, Marshall Wace LLP acquired a new position in Pro-Dex in the fourth quarter valued at about $433,000. Institutional investors own 15.28% of the company's stock.

Analyst Ratings Changes

Separately, StockNews.com cut Pro-Dex from a "buy" rating to a "hold" rating in a report on Wednesday, March 12th.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.